Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia
2018 · Cell Death and Disease · 37 citations
https://doi.org/10.1038/s41419-018-0964-4
M
Min H. Kang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
255
Papers
6.6K
Citations
42
h-index
92
i10-index
Min H. Kang is an academic researcher from Texas Tech University. The author has contributed to research in topics: Neuroblastoma Research and Treatments & Cancer therapeutics and mechanisms & Retinoids in leukemia and cellular processes. The author has an h-index of 42, co-authored 217 publications.
ORCID: 0000-0003-3603-7035Papers by this author
worksProbable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study
2014 · BMC Research Notes · 10 citations
https://doi.org/10.1186/1756-0500-7-256
Stratification of telomerase activity in cancer reveals associations with senescence and genomic instability
2025 · Computational and Structural Biotechnology Journal · 0 citations
https://doi.org/10.1016/j.csbj.2025.11.020
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat